Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;188(3):751-759.
doi: 10.1002/ajmg.a.62566. Epub 2021 Nov 9.

Pseudoachondroplasia: Phenotype and genotype in 11 Indian patients

Prince Jacob  1 , Gandham Sri Lakshmi Bhavani  1 , Hitesh Shah  2 , Chelna Galada  1 , Sheela Nampoothiri  3 , Nutan Kamath  4 , Shubha R Phadke  5 , Mamta Muranjan  6 , Chaitanya A Datar  7 , Anju Shukla  1 , Katta M Girisha  1
Affiliations

Pseudoachondroplasia: Phenotype and genotype in 11 Indian patients

Prince Jacob et al. Am J Med Genet A. 2022 Mar.

Abstract

Pseudoachondroplasia (PSACH) is an autosomal dominant disorder characterized by rhizomelic short-limbed skeletal dysplasia. The primary clinical and radiographic features include disproportionate dwarfism, joint laxity and hyperextensibility, exaggerated lumbar lordosis, and late ossification of the epiphyses. Identification of disease-causing variants in heterozygous state in COMP establishes the molecular diagnosis of PSACH. We examined 11 families with clinical features suggestive of PSACH. In nine families, we used Sanger sequencing of exons 8-19 of COMP (NM_000095.2) and in two families exome sequencing was used for confirming the diagnosis. We identified 10 de novo variants, including five known variants (c.925G>A, c.976G>A, c.1201G>T, c.1417_1419del, and c.1511G>A) and five variants (c.874T>C, c.1201G>C, c.1309G>A, c.1416_1421delCGACAA, and c.1445A>T) which are not reported outside Indian ethnicity. We hereby report the largest series of individuals with molecular diagnosis of PSACH from India and reiterate the well-known genotype-phenotype corelation in PSACH.

Keywords: COMP; autosomal dominant; psuedoachondroplasia.

PubMed Disclaimer

References

REFERENCES

    1. Briggs, M. D., Brock, J., Ramsden, S. C., & Bell, P. A. (2014). Genotype to phenotype correlations in cartilage oligomeric matrix protein associated chondrodysplasias. European Journal of Human Genetics, 22(11), 1278-1282. https://doi.org/10.1038/ejhg.2014.30
    1. Briggs, M. D., & Chapman, K. L. (2002). Pseudoachondroplasia and multiple epiphyseal dysplasia: Mutation review, molecular interactions, and genotype to phenotype correlations. Human Mutation, 19(5), 465-478. https://doi.org/10.1002/humu.10066
    1. Briggs, M. D., Hoffman, S. M. G., King, L. M., Olsen, A. S., Mohrenweiser, H., Leroy, J. G., Mortier, G. R., Rimoin, D. L., Lachman, R. S., Gaines, E. S., Cekleniak, J. A., Knowlton, R. G., & Cohn, D. H. (1995). Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nature Genetics, 10(3), 330-336. https://doi.org/10.1038/ng0795-330
    1. Briggs, M. D., Mortier, G. R., Cole, W. G., King, L. M., Golik, S. S., Bonaventure, J., Nuytinck, L., De Paepe, A., Leroy, J. G., Biesecker, L., Lipson, M., Wilcox, W. R., Lachman, R. S., Rimoin, D. L., Knowlton, R. G., & Cohn, D. H. (1998). Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. American Journal of Human Genetics, 62(2), 311-319. https://doi.org/10.1086/301713
    1. Cao, L. H., Wang, L. B., Wang, S. S., Ma, H. W., Ji, C. Y., & Luo, Y. (2011). Identification of novel and recurrent mutations in the calcium binding type III repeats of cartilage oligomeric matrix protein in patients with pseudoachondroplasia. Genetics and Molecular Research, 10(2), 955-963. https://doi.org/10.4238/vol10-2gmr1111

Publication types

Substances

Supplementary concepts

LinkOut - more resources